Advertisement

Topics

Infectious-diseases Corporate

17:18 EDT 21st September 2018 | BioPortfolio

MicuRx Pharmaceuticals, Inc.

MicuRx is discovering and developing novel antibiotics to combat infections due to resistant bacteria. Positioned to capture the benefits of United States research and development expertise together with China's abundant scientific talent and cost-effective discovery, preclinical and development, the company has built a pipeline of drug candidates for the treatment of gram positive, gram negative ...

Virion Biotherapeutics

Virion Biotherapeutics seeks to transform the management of respiratory viral infections with the development of its proprietary Therapeutic Interfering Particles (TIPs). These first-in-class biologicals enhance a naturally-occurring dual mechanism that interferes with viral replication, preventing infection and stopping disease, enabling treatment of the ...

Finch Therapeutics Group, Inc.

Finch Therapeutics Group is developing novel microbial therapies to serve patients with serious unmet medical needs. Founded by data scientists, clinicians, and microbiologists from MIT and OpenBiome, Finch uses innovative machine-learning algorithms informed by high-throughput molecular data to reverse engineer successful clinical experience, building upo...

Mobidiag

Founded in the year 2000, Mobidiag is specialized in the molecular diagnostics of infectious diseases. The focus area of the company is primarily to develop high-quality content for DNA biochip-based diagnostic assays. Mobidiag has selected clinically relevant panels of bacteria and other infectious disease markers and is developing efficient DNA detection technology for their analysis. Mobidiagâ...

FluGen Inc.

FluGen, Inc. is a clinical stage vaccine company focused on improving the breadth and effectiveness of influenza vaccines. The Company’s technology comes from the laboratory of Dr. Yoshihiro Kawaoka at the University of Wisconsin, Madison. It’s lead product candidate, RedeeFlu™ is a universal flu vaccine which is based on the knowledge that a ...

Aus Bio Ltd.

Aus Bio Ltd. is a public but unlisted, Melbourne based biotechnology research and development company. It develops innovative research program to create new therapeutic products for specific disease states. Aus Bio is uniquely placed to develop the next generation therapeutics to combat influenza as Aus Bio’s senior scientists were closely involved, w...

Seqirus

In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.1,2 CVVs are prepared by the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS) and associated laboratories, and ...

Akeso Biomedical, Inc.

Akeso Biomedical, Inc. is an animal health and food safety company developing new solutions to improve animal welfare and performance and to prevent foodborne illnesses. Akeso uses a proprietary broad-spectrum iron chelate chemistry known as Fe3C. The Company’s product pipeline includes Fe3C feed additives designed to improve intestinal health and nut...

Appili Therapeutics Inc.

Appili is dedicated to identifying, acquiring and advancing novel therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is a taste-masked treatment for anaerobic infections, including C. difficile. Appili’s second product, ATI-1503, is a novel antibiotic with broad potential ...

Discuva

Discuva aims to revolutionise the treatment of disease caused by bacterial infection by discovering and developing new antibiotics against highly drug-resistant pathogens. The company’s innovative proprietary technologies both identify new small molecule drugs against novel bacterial targets and facilitate their progression through to drug candidates ...

Arsanis, Inc.

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...

Trinity Guardion

Founded in 2010 and based in Batesville, IN, Trinity Guardion manufactures the world’s only launderable bed cover system and pillow cases for hospital beds and bed decks that is specifically engineered to eliminate bacteria such as Clostridium difficile (C. diff). The Trinity Bed System Protection System™, resulting from collaboration of internat...

GenArraytion, Inc.

Based in Rockville, Md., GenArraytion, Inc. is a privately held, veteran-owned, small business dedicated to the development and commercialization of multiplexed molecular assays for infectious diseases. GenArraytion is dedicated to improving healthcare through the development and distribution of treatment-guiding molecular assays for infectious disease mar...

Telephus Medical LLC

Telephus Medical, located in San Diego, California, is developing a suite of monoclonal antibody products designed to neutralize key staphylococcal enzymes used to attach to host tissues, replicate and evade immune attack. These enzymes, are central components of the bacterial machinery staphylococci utilize to invade host tissues, evade the immune respons...

Getinge Group

Getinge Infection Control (Getinge) is one of three business areas within Getinge Group, a publicly-listed, Swedish-based group of companies. The Getinge Infection Control business area consists of two divisions; Healthcare and Life Science. For the Healthcare sector, Getinge provides solutions for infection control whereas for the Life Science sector, Get...

The Center for Infectious Disease Research

The Center for Infectious Disease Research is the largest independent, nonprofit organization in the U.S. focused solely on infectious disease research. Our mission is to make transformative scientific advancements that lead to the prevention and treatment of infectious diseases. We advance the science to develop vaccines, drugs, and diagnostics for infect...

Society for Adolescent Health and Medicine

Immunization is critically important for adolescents because they are at risk for serious and potentially life-threatening diseases.

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented at the University of Wisconsin-Madison, in the laboratories of Dr. Yoshihiro Kawaoka and Dr. Gabriele Neumann, and exclusively licensed to FluGen by WARF. The REDEE FLU influenza ...

MeMed Ltd.

MeMed is dedicated to improving patient lives through research, development and commercialization of pioneering products that decode the immune system's distinct responses to different health and disease states. The company focuses on providing rapid, accurate and actionable diagnostic solutions for acute infectious diseases and inflammatory disorders in t...

Center for Infectious Disease Research

Center for Infectious Disease Research is the largest independent, non-profit organization in the U.S. focused solely on infectious disease research. Our mission is to make transformative scientific advancements that lead to the prevention and treatment of infectious diseases. We advance the science to develop vaccines, drugs, and diagnostics for infectiou...

Gemmus Pharma, Inc.

Gemmus is a privately held pharmaceutical company focused on the development of innovative products for the treatment of infectious diseases by modulating the host response to the disease. Gemmus was founded in 2007 to develop EP2 and EP4 agonists for the treatment of influenza and in-licensed technology from a major pharmaceutical company. The company has...

Eurogentec

Contract antibody manufacturer of monoclonals, polyclonals, peptides - gene plasmid DNA immunization.

Summit Therapeutics plc

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease Clostridium difficile infection.

Getinge Infection Control AB

Getinge Group is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, Getinge and Maquet. ArjoHuntleigh focuses on patient mobility and wound management solutions. Getinge provides solutions for infection control ...

Summit Corporation plc

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease Clostridium difficile infection. Summi...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Infectious-diseases market research data and corporate reports here